News

Pharmabiz11h
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product
Navamedic: First approval of the medical device OraFID as primary package for a pharmaceutical product: Oslo, Norway Monday, June 30, 2025, 17:00 Hrs [IST] Navamedic, a Nordic pha ...
Pharmabiz18h
Sobi’s Gamifant receives US FDA approval for first-ever treatment for adults and children with MAS in Still's disease
Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...
Pharmabiz16h
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management
China NMPA approves Innovent’s mazdutide, first dual GCG/GLP-1 receptor agonist for chronic weight management: San Francisco, US Monday, June 30, 2025, 12:00 Hrs [IST] Innovent ...
Pharmabiz7h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics Corporation (Bone Biologics), a developer of orthobiologic products for spine fusion markets, announces the filing of a patent application with the United States Patent and Trademark ...
Pharmabiz17h
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints
UCB announces phase 3 study of fenfluramine in CDKL5 deficiency disorder meets primary and key secondary endpoints: Brussels, Belgium Monday, June 30, 2025, 11:00 Hrs [IST] UCB, a ...
Pharmabiz20h
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC
SLAs can invoke provisions of restricted license to ensure availability of pharmacists in rural areas: DCC: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drug ...
Pharmabiz9h
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US
BioPorto A/S, an in vitro diagnostics company, announced the initiation of commercialization in the US of ProNephro AKI (NGAL) for clinical use in risk stratification for moderate-to-severe AKI for ...
Pharmabiz19h
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar
PharmaTech Expo & LabTech Expo 2025 to be held from August 5 to 7 in Gandhinagar: Our Bureau, Mumbai Monday, June 30, 2025, 09:00 Hrs [IST] PharmatechnologyIndex.com Pvt Ltd is pl ...
Pharmabiz17h
Torrent Pharma to acquire controlling stake in JB Chemicals & Pharmaceuticals
Torrent Pharmaceuticals has announced acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd from New York-based global investment firm KKR, with plans to merge the two entities ...
Pharmabiz10h
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies
The US Food and Drug Administration (FDA) announced that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently approved BCMA- and CD19-directed autologous chimeric ...
Pharmabiz20h
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules
DCC agrees with proposal to include Good Distribution Practices as part of Drugs Rules: Gireesh Babu, New Delhi Monday, June 30, 2025, 08:00 Hrs [IST] The Drugs Consultative Commi ...
Pharmabiz20h
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain
Pharmexcil, USP discuss collaboration on biosimilar accessibility, building resilient supply chain: Shardul Nautiyal, Mumbai Monday, June 30, 2025, 08:00 Hrs [IST] The Pharmaceuti ...